Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001461247-10-000001
Filing Date
2010-04-29
Accepted
2010-04-28 17:47:16
Documents
1
Effectiveness Date
2010-04-29
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6095
  Complete submission text file 0001461247-10-000001.txt   7674
Mailing Address 600 LEXINGTON AVENUE 31ST FLOOR NEW YORK NY 10022
Business Address 600 LEXINGTON AVENUE 31ST FLOOR NEW YORK NY 10022 (212) 754-6077
Welch Life Sciences Fund, L.P. (Filer) CIK: 0001461247 (see all company filings)

EIN.: 134113978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-130157 | Film No.: 10778110